Review of the adenocarcinoma cell surface receptor for human alpha-fetoprotein; proposed identification of a widespread mucin as the tumor cell receptor
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Review of the adenocarcinoma cell surface receptor for human alpha-fetoprotein; proposed identification of a widespread mucin as the tumor cell receptor
Authors
Keywords
Alpha fetoprotein, Adenocarcinomas, MUC4, RECAF, Breast cells, Dendritic cells, Mucins, Tumor cells
Journal
TUMOR BIOLOGY
Volume 34, Issue 3, Pages 1317-1336
Publisher
Springer Nature
Online
2013-02-27
DOI
10.1007/s13277-013-0704-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies
- (2012) Albert C. Chen et al. BREAST CANCER RESEARCH AND TREATMENT
- Mapping the Protein Domain Structures of the Respiratory Mucins: A Mucin Proteome Coverage Study
- (2012) Rui Cao et al. JOURNAL OF PROTEOME RESEARCH
- Role of MUC4–NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells
- (2011) S Senapati et al. ONCOGENE
- Mucins in human neoplasms: Clinical pathology, gene expression and diagnostic application
- (2011) Suguru Yonezawa et al. PATHOLOGY INTERNATIONAL
- Monoclonal Antibodies Recognizing the Non-Tandem Repeat Regions of the Human Mucin MUC4 in Pancreatic Cancer
- (2011) Maneesh Jain et al. PLoS One
- Combination of CA125 and RECAF biomarkers for early detection of ovarian cancer
- (2011) Janneta Tcherkassova et al. TUMOR BIOLOGY
- MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells
- (2011) Moorthy P Ponnusamy et al. Journal of Ovarian Research
- Mechanism of Cancer Growth Suppression of Alpha-Fetoprotein Derived Growth Inhibitory Peptides (GIP): Comparison of GIP-34 versus GIP-8 (AFPep). Updates and Prospects
- (2011) Gerald Mizejewski Cancers
- Activity of recombinant cysteine-rich domain proteins derived from the membrane-bound MUC17/Muc3 family mucins
- (2010) Samuel B. Ho et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Molecular cloning of two novel mucin-like genes in the disease-susceptibility locus for diffuse panbronchiolitis
- (2010) Minako Hijikata et al. HUMAN GENETICS
- Targeted delivery of anti-cancer growth inhibitory peptides derived from human α-fetoprotein: review of an International Multi-Center Collaborative Study
- (2010) GJ Mizejewski et al. JOURNAL OF DRUG TARGETING
- Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes
- (2010) Jennifer A. Belisle et al. Molecular Cancer
- Review of the putative cell-surface receptors for alpha-fetoprotein: identification of a candidate receptor protein family
- (2010) Gerald J. Mizejewski TUMOR BIOLOGY
- Cytoplasmic alpha-fetoprotein functions as a co-repressor in RA-RAR signaling to promote the growth of human hepatoma Bel 7402 cells
- (2009) Mengsen Li et al. CANCER LETTERS
- The Membrane Mucin Muc4 Inhibits Apoptosis Induced by Multiple Insults via ErbB2-Dependent and ErbB2-Independent Mechanisms
- (2009) H. C. Workman et al. CANCER RESEARCH
- MUC4, a Multifunctional Transmembrane Glycoprotein, Induces Oncogenic Transformation of NIH3T3 Mouse Fibroblast Cells
- (2008) S. Bafna et al. CANCER RESEARCH
- MUC4 Mucin Interacts with and Stabilizes the HER2 Oncoprotein in Human Pancreatic Cancer Cells
- (2008) P. Chaturvedi et al. CANCER RESEARCH
- Recombinant alpha-fetoprotein C-terminal fragment: The new recombinant vector for targeted delivery
- (2008) Galina A. Posypanova et al. JOURNAL OF DRUG TARGETING
- Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior
- (2008) Suguru Yonezawa et al. PROTEOMICS
- Structure, evolution, and biology of the MUC4 mucin
- (2007) Pallavi Chaturvedi et al. FASEB JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now